The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


The Journal of Immunology, 2009, 182, 1202 -1210
Copyright © 2009 by The American Association of Immunologists, Inc.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chung, A. W.
Right arrow Articles by Stratov, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chung, A. W.
Right arrow Articles by Stratov, I.

Rapid Degranulation of NK Cells following Activation by HIV-Specific Antibodies1

Amy W. Chung*, Erik Rollman*, Rob J. Center*, Stephen J. Kent2,*,{dagger},{ddagger} and Ivan Stratov*,{dagger},{ddagger},§

* Department of Microbiology and Immunology, University of Melbourne, Melbourne, Australia; {dagger} Melbourne Sexual Health Centre, Carlton, Australia; {ddagger} Infectious Diseases Department, Alfred Hospital, Prahran, Australia; and § Burnet Institute, Prahran, Australia

Ab-dependent cellular cytotoxicity (ADCC) Abs stimulate NK cell effector functions and play a role in protecting from and controlling viral infections. We characterized ADCC Abs in a cross-sectional cohort of 80 HIV-infected subjects not on antiretroviral therapy. We analyzed ADCC response by killing fluorescently labeled target cells, as well as expression of IFN-{gamma} and the degranulation marker CD107a from activated NK cells as measured by a novel intracellular cytokine assay. HIV-specific ADCC directed toward Envelope proteins were present in the majority of 80 untreated HIV-infected individuals measured by killing function. Similarly, most subjects had HIV-specific Abs that mediated degranulation or cytokine expression by NK cells. Interestingly, there was a poor correlation between ADCC-mediated killing of fluorescently labeled whole Envelope protein-pulsed cell lines and Ab-mediated expression of IFN-{gamma} by NK cells. However, in contrast to healthy donor NK cells, autologous patient NK cells more effectively degranulated granzyme B in response to ADCC activation. Activation of NK cells in response to stimulation by HIV-specific Abs occurs at least as rapidly as activation of Gag-specific CTLs. Our studies highlight the complexity of ab-mediated NK cell activation in HIV infection, and suggest new avenues toward studying the utility of ADCC in controlling HIV infection.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked advertisement in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

1 Supported by Australian National Health and Medical Research Council awards 299907, 359233, and 251654, and Swedish Research Council Fellowship 2005-2527.

2 Address correspondence to Prof. Kent, Department of Microbiology and Immunology, University of Melbourne, 3010 Australia. E-mail address: skent{at}unimelb.edu.au

3 Abbreviations used in this paper: Nab, neutralizing Ab; ADCC, Ab-dependent cellular cytotoxicity; Env, Envelope; ICS, intracellular cytokine staining; KIR, killer Ig-related receptor; RFADCC, rapid fluorescent ADCC; NCR, natural cytotoxicity receptor.




This article has been cited by other articles:


Home page
JEMHome page
N. Goonetilleke, M. K.P. Liu, J. F. Salazar-Gonzalez, G. Ferrari, E. Giorgi, V. V. Ganusov, B. F. Keele, G. H. Learn, E. L. Turnbull, M. G. Salazar, et al.
The first T cell response to transmitted/founder virus contributes to the control of acute viremia in HIV-1 infection
J. Exp. Med., June 8, 2009; 206(6): 1253 - 1272.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2009 by The American Association of Immunologists, Inc. All rights reserved.